Reviva (Nasdaq: RVPH) is a late-stage biopharmaceutical company that discovers, develops, and seeks to commercialize next-generation therapeutics for diseases representing unmet medical needs and burdens to society, patients, and their families.

This fireside chat was recorded during the Lytham Partners Fall 2025 Investor Conference.